Page last updated: 2024-10-25

ciprofloxacin and Leishmaniasis, Visceral

ciprofloxacin has been researched along with Leishmaniasis, Visceral in 3 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bharate, SB1
Bharate, JB1
Khan, SI1
Tekwani, BL1
Jacob, MR1
Mudududdla, R1
Yadav, RR1
Singh, B2
Sharma, PR1
Maity, S1
Khan, IA1
Vishwakarma, RA1
Sanal, O1
Turkkani, G1
Gumruk, F1
Yel, L1
Secmeer, G1
Tezcan, I1
Kara, A1
Ersoy, F1
Muñoz Sanz, A1

Other Studies

3 other studies available for ciprofloxacin and Leishmaniasis, Visceral

ArticleYear
Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
    European journal of medicinal chemistry, 2013, Volume: 63

    Topics: Antiprotozoal Agents; Drug Discovery; Humans; Indoles; Inhibitory Concentration 50; Leishmania donov

2013
A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:4

    Topics: Amphotericin B; Anti-Infective Agents; Antiprotozoal Agents; Child, Preschool; Ciprofloxacin; Geneti

2007
[Visceral leishmaniasis and ciprofloxacin].
    Medicina clinica, 1996, Oct-26, Volume: 107, Issue:14

    Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Leishmaniasis, Visceral

1996